Winfield Associates’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-3,300
Closed -$240K 246
2017
Q4
$240K Sell
3,300
-535
-14% -$38.9K 0.12% 112
2017
Q3
$312K Buy
3,835
+15
+0.4% +$1.19K 0.16% 101
2017
Q2
$308K Sell
3,820
-95
-2% -$7.5K 0.17% 98
2017
Q1
$308K Buy
3,915
+130
+3% +$10.4K 0.18% 100
2016
Q4
$299K Sell
3,785
-3,149
-45% -$255K 0.18% 96
2016
Q3
$617K Sell
6,934
-235
-3% -$22.2K 0.39% 71
2016
Q2
$686K Buy
7,169
+305
+4% +$30.4K 0.45% 61
2016
Q1
$712K Buy
6,864
+714
+12% +$69.4K 0.48% 56
2015
Q4
$601K Buy
6,150
+1,800
+41% +$176K 0.4% 62
2015
Q3
$420K Buy
4,350
+600
+16% +$63.1K 0.31% 68
2015
Q2
$393K Hold
3,750
0.27% 81
2015
Q1
$387K Sell
3,750
-52
-1% -$5.26K 0.27% 83
2014
Q4
$366K Buy
3,802
+52
+1% +$4.58K 0.27% 86
2014
Q3
$298K Sell
3,750
-3,600
-49% -$284K 0.22% 98
2014
Q2
$553K Sell
7,350
-100
-1% -$7.56K 0.4% 77
2014
Q1
$558K Buy
7,450
+130
+2% +$9.18K 0.46% 73
2013
Q4
$524K Buy
+7,320
New +$470K 0.43% 75

Other funds holding CVS

Winfield Associates's CVS Position: Q1 2018 in Review

Winfield Associates sold out of CVS Health (CVS) in Q1 2018, closing a stake of 3,300 shares — an estimated $240K sold.

Winfield Associates first reported a position in CVS in Q4 2013 and held it in 17 quarters. The position peaked at $712K in Q1 2016. 1,549 funds tracked by Wall St. Rank hold CVS as of Q1 2018.

  • Winfield Associates reported no remaining CVS Health position as of Q1 2018 after selling out during the quarter.
  • Winfield Associates sold 3,300 CVS Health shares in Q1 2018, an estimated $240K.
  • Winfield Associates first reported a position in CVS Health in Q4 2013 and held it in 17 quarters.
  • Winfield Associates's CVS Health position peaked at $712K in Q1 2016.
  • 1,549 funds tracked by Wall St. Rank held CVS Health as of Q1 2018.

Based on Winfield Associates's 13F filing for Q1 2018, filed 10 May 2018.